Company Filing History:
4 out of 44 
1 out of 1 Years Active: 2017-2019
Title: The Innovative Mind of Shun-ichi Ohba
Introduction
Shun-ichi Ohba, based in Tokyo, Japan, is a notable inventor with a significant contribution to the field of pharmaceutical innovations. With a total of four patents to his name, Ohba has focused his research on developing compounds that inhibit cancer cell growth and provide therapeutic benefits in cancer treatment.
Latest Patents
Among his latest patents, Ohba has introduced a groundbreaking compound, along with its production method and usage. This novel compound possesses anti-cancer properties and offers pharmaceutical compositions aimed at addressing cancer cell proliferation. Additionally, his work includes a cancer cell proliferation inhibitor that features compounds represented by specific structural formulae, targeting cancer cells that overexpress a wild-type epidermal growth factor receptor or express an epidermal growth factor receptor mutant vIII.
Career Highlights
Throughout his career, Shun-ichi Ohba has contributed to various research initiatives and projects. He has worked with the Microbial Chemistry Research Foundation, where he has collaborated on numerous innovative solutions aimed at advancing scientific knowledge and practical applications in medicine. Additionally, he has been associated with Gakubunkan, further enhancing his expertise in scientific research and development.
Collaborations
Ohba's journey as an inventor has seen him collaborate with prominent professionals in the field, including Manabu Kawada and Hikaru Abe. These collaborations have played a significant role in enhancing the scope and impact of his inventions, showcasing a collective effort to drive forward innovative solutions in cancer treatment.
Conclusion
Shun-ichi Ohba stands out as a pioneering inventor with a focused vision towards combating cancer through innovative compound development. His contributions not only represent significant advancements in pharmaceutical science but also share hope for effective cancer therapies, reinforcing the importance of research collaboration in achieving impactful innovations.